Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 51 entries
Sorted by: Best Match Show Resources per page
Electrophysiological Advances on Multiple Object Processing in Aging.

Frontiers in aging neuroscience

Mazza V, Brignani D.
PMID: 26973520
Front Aging Neurosci. 2016 Mar 02;8:46. doi: 10.3389/fnagi.2016.00046. eCollection 2016.

EEG research conducted in the past 5 years on multiple object processing has begun to define how the aging brain tracks the numerosity of the objects presented in the visual field for different goals. We review the recent EEG...

Cite
Mazza V, Brignani D. Electrophysiological Advances on Multiple Object Processing in Aging. Front Aging Neurosci. 2016;8:46doi: 10.3389/fnagi.2016.00046.
Mazza, V., & Brignani, D. (2016). Electrophysiological Advances on Multiple Object Processing in Aging. Frontiers in aging neuroscience, 846. https://doi.org/10.3389/fnagi.2016.00046
Mazza, Veronica, and Brignani, Debora. "Electrophysiological Advances on Multiple Object Processing in Aging." Frontiers in aging neuroscience vol. 8 (2016): 46. doi: https://doi.org/10.3389/fnagi.2016.00046
Mazza V, Brignani D. Electrophysiological Advances on Multiple Object Processing in Aging. Front Aging Neurosci. 2016 Mar 02;8:46. doi: 10.3389/fnagi.2016.00046. eCollection 2016. PMID: 26973520; PMCID: PMC4773734.
Copy Download .nbib Format: NLM
ANMCO Position Paper: diagnostic-therapeutic pathway in patients with hypercholesterolaemia and statin intolerance.

European heart journal supplements : journal of the European Society of Cardiology

Gulizia MM, Colivicchi F, Arca M, Abrignani MG, Perna GP, Mureddu GF, Nardi F, Riccio C.
PMID: 28751834
Eur Heart J Suppl. 2017 May;19:D55-D63. doi: 10.1093/eurheartj/sux020. Epub 2017 May 02.

Statins are a class of drugs used to lower total and low-density lipoprotein (LDL)-cholesterol. Clinical trials performed over the last 25 years have shown that these agents are effective in improving cardiovascular outcomes in several different clinical settings. However,...

Cite
Gulizia MM, Colivicchi F, Arca M, et al. ANMCO Position Paper: diagnostic-therapeutic pathway in patients with hypercholesterolaemia and statin intolerance. Eur Heart J Suppl. 2017;19:D55-D63doi: 10.1093/eurheartj/sux020.
Gulizia, M. M., Colivicchi, F., Arca, M., Abrignani, M. G., Perna, G. P., Mureddu, G. F., Nardi, F., Riccio, C. (2017). ANMCO Position Paper: diagnostic-therapeutic pathway in patients with hypercholesterolaemia and statin intolerance. European heart journal supplements : journal of the European Society of Cardiology, 19D55-D63. https://doi.org/10.1093/eurheartj/sux020
Gulizia, Michele Massimo, et al. "ANMCO Position Paper: diagnostic-therapeutic pathway in patients with hypercholesterolaemia and statin intolerance." European heart journal supplements : journal of the European Society of Cardiology vol. 19 (2017): D55-D63. doi: https://doi.org/10.1093/eurheartj/sux020
Gulizia MM, Colivicchi F, Arca M, Abrignani MG, Perna GP, Mureddu GF, Nardi F, Riccio C. ANMCO Position Paper: diagnostic-therapeutic pathway in patients with hypercholesterolaemia and statin intolerance. Eur Heart J Suppl. 2017 May;19:D55-D63. doi: 10.1093/eurheartj/sux020. Epub 2017 May 02. PMID: 28751834; PMCID: PMC5520756.
Copy Download .nbib Format: NLM
Erratum to: A prospective study of the cumulative incidence and course of restless legs syndrome in de novo patients with Parkinson's disease during chronic dopaminergic therapy.

Journal of neurology

Marchesi E, Negrotti A, Angelini M, Goldoni M, Abrignani G, Calzetti S.
PMID: 26895039
J Neurol. 2016 Mar;263(3):448. doi: 10.1007/s00415-016-8044-0.

No abstract available.

Cite
Marchesi E, Negrotti A, Angelini M, et al. Erratum to: A prospective study of the cumulative incidence and course of restless legs syndrome in de novo patients with Parkinson's disease during chronic dopaminergic therapy. J Neurol. 2016;263(3):448doi: 10.1007/s00415-016-8044-0.
Marchesi, E., Negrotti, A., Angelini, M., Goldoni, M., Abrignani, G., & Calzetti, S. (2016). Erratum to: A prospective study of the cumulative incidence and course of restless legs syndrome in de novo patients with Parkinson's disease during chronic dopaminergic therapy. Journal of neurology, 263(3), 448. https://doi.org/10.1007/s00415-016-8044-0
Marchesi, Elena, et al. "Erratum to: A prospective study of the cumulative incidence and course of restless legs syndrome in de novo patients with Parkinson's disease during chronic dopaminergic therapy." Journal of neurology vol. 263,3 (2016): 448. doi: https://doi.org/10.1007/s00415-016-8044-0
Marchesi E, Negrotti A, Angelini M, Goldoni M, Abrignani G, Calzetti S. Erratum to: A prospective study of the cumulative incidence and course of restless legs syndrome in de novo patients with Parkinson's disease during chronic dopaminergic therapy. J Neurol. 2016 Mar;263(3):448. doi: 10.1007/s00415-016-8044-0. PMID: 26895039.
Copy Download .nbib Format: NLM
Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease.

European heart journal supplements : journal of the European Society of Cardiology

Gulizia MM, Colivicchi F, Abrignani MG, Ambrosetti M, Aspromonte N, Barile G, Caporale R, Casolo G, Chiuini E, Di Lenarda A, Faggiano P, Gabrielli D, Geraci G, La Manna AG, Maggioni AP, Marchese A, Massari FM, Mureddu GF, Musumeci G, Nardi F, Panno AV, Pedretti RFE, Piredda M, Pusineri E, Riccio C, Rossini R, di Uccio FS, Urbinati S, Varbella F, Zito GB, De Luca L.
PMID: 29867293
Eur Heart J Suppl. 2018 May;20:F1-F74. doi: 10.1093/eurheartj/suy019. Epub 2018 May 31.

Dual antiplatelet therapy (DAPT) with aspirin and a P2Y

Cite
Gulizia MM, Colivicchi F, Abrignani MG, et al. Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease. Eur Heart J Suppl. 2018;20:F1-F74doi: 10.1093/eurheartj/suy019.
Gulizia, M. M., Colivicchi, F., Abrignani, M. G., Ambrosetti, M., Aspromonte, N., Barile, G., Caporale, R., Casolo, G., Chiuini, E., Di Lenarda, A., Faggiano, P., Gabrielli, D., Geraci, G., La Manna, A. G., Maggioni, A. P., Marchese, A., Massari, F. M., Mureddu, G. F., Musumeci, G., Nardi, F., Panno, A. V., Pedretti, R. F. E., Piredda, M., Pusineri, E., Riccio, C., Rossini, R., di Uccio, F. S., Urbinati, S., Varbella, F., Zito, G. B., De Luca, L. (2018). Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease. European heart journal supplements : journal of the European Society of Cardiology, 20F1-F74. https://doi.org/10.1093/eurheartj/suy019
Gulizia, Michele Massimo, et al. "Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease." European heart journal supplements : journal of the European Society of Cardiology vol. 20 (2018): F1-F74. doi: https://doi.org/10.1093/eurheartj/suy019
Gulizia MM, Colivicchi F, Abrignani MG, Ambrosetti M, Aspromonte N, Barile G, Caporale R, Casolo G, Chiuini E, Di Lenarda A, Faggiano P, Gabrielli D, Geraci G, La Manna AG, Maggioni AP, Marchese A, Massari FM, Mureddu GF, Musumeci G, Nardi F, Panno AV, Pedretti RFE, Piredda M, Pusineri E, Riccio C, Rossini R, di Uccio FS, Urbinati S, Varbella F, Zito GB, De Luca L. Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease. Eur Heart J Suppl. 2018 May;20:F1-F74. doi: 10.1093/eurheartj/suy019. Epub 2018 May 31. PMID: 29867293; PMCID: PMC5978022.
Copy Download .nbib Format: NLM
Functional Imaging to Guide Network-Based TMS Treatments: Toward a Tailored Medicine Approach in Alzheimer's Disease.

Frontiers in neuroscience

Bagattini C, Brignani D, Bonnì S, Quattrini G, Gasparotti R, Pievani M.
PMID: 34290585
Front Neurosci. 2021 Jul 05;15:687493. doi: 10.3389/fnins.2021.687493. eCollection 2021.

A growing number of studies is using fMRI-based connectivity to guide transcranial magnetic stimulation (TMS) target identification in both normal and clinical populations. TMS has gained increasing attention as a potential therapeutic strategy also in Alzheimer's disease (AD), but...

Cite
Bagattini C, Brignani D, Bonnì S, et al. Functional Imaging to Guide Network-Based TMS Treatments: Toward a Tailored Medicine Approach in Alzheimer's Disease. Front Neurosci. 2021;15:687493doi: 10.3389/fnins.2021.687493.
Bagattini, C., Brignani, D., Bonnì, S., Quattrini, G., Gasparotti, R., & Pievani, M. (2021). Functional Imaging to Guide Network-Based TMS Treatments: Toward a Tailored Medicine Approach in Alzheimer's Disease. Frontiers in neuroscience, 15687493. https://doi.org/10.3389/fnins.2021.687493
Bagattini, Chiara, et al. "Functional Imaging to Guide Network-Based TMS Treatments: Toward a Tailored Medicine Approach in Alzheimer's Disease." Frontiers in neuroscience vol. 15 (2021): 687493. doi: https://doi.org/10.3389/fnins.2021.687493
Bagattini C, Brignani D, Bonnì S, Quattrini G, Gasparotti R, Pievani M. Functional Imaging to Guide Network-Based TMS Treatments: Toward a Tailored Medicine Approach in Alzheimer's Disease. Front Neurosci. 2021 Jul 05;15:687493. doi: 10.3389/fnins.2021.687493. eCollection 2021. PMID: 34290585; PMCID: PMC8287201.
Copy Download .nbib Format: NLM
Protocol for tissue clearing and 3D analysis of dopamine neurons in the developing mouse midbrain.

STAR protocols

Adolfs Y, Raj DDA, Brignani S, Pasterkamp RJ.
PMID: 34377993
STAR Protoc. 2021 Jul 22;2(3):100669. doi: 10.1016/j.xpro.2021.100669. eCollection 2021 Sep 17.

Advances in tissue clearing enable analysis of complex migratory patterns of developing neurons in whole intact tissue. Here, we implemented a modified version of 3DISCO to study migration of midbrain dopamine (DA) neurons. We provide a detailed protocol starting...

Cite
Adolfs Y, Raj DDA, Brignani S, et al. Protocol for tissue clearing and 3D analysis of dopamine neurons in the developing mouse midbrain. STAR Protoc. 2021;2(3):100669doi: 10.1016/j.xpro.2021.100669.
Adolfs, Y., Raj, D. D. A., Brignani, S., & Pasterkamp, R. J. (2021). Protocol for tissue clearing and 3D analysis of dopamine neurons in the developing mouse midbrain. STAR protocols, 2(3), 100669. https://doi.org/10.1016/j.xpro.2021.100669
Adolfs, Youri, et al. "Protocol for tissue clearing and 3D analysis of dopamine neurons in the developing mouse midbrain." STAR protocols vol. 2,3 (2021): 100669. doi: https://doi.org/10.1016/j.xpro.2021.100669
Adolfs Y, Raj DDA, Brignani S, Pasterkamp RJ. Protocol for tissue clearing and 3D analysis of dopamine neurons in the developing mouse midbrain. STAR Protoc. 2021 Jul 22;2(3):100669. doi: 10.1016/j.xpro.2021.100669. eCollection 2021 Sep 17. PMID: 34377993; PMCID: PMC8326876.
Copy Download .nbib Format: NLM
Corrigendum to: Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel Diseases.

Journal of Crohn's & colitis

Coletta M, Paroni M, Alvisi MF, De Luca M, Rulli E, Mazza S, Facciotti F, Lattanzi G, Strati F, Abrignani S, Claudio Fantini M, Vecchi M, Geginat J, Capriolia F.
PMID: 34850867
J Crohns Colitis. 2021 Nov 30; doi: 10.1093/ecco-jcc/jjab107. Epub 2021 Nov 30.

No abstract available.

Cite
Coletta M, Paroni M, Alvisi MF, et al. Corrigendum to: Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel Diseases. J Crohns Colitis. 2021;doi: 10.1093/ecco-jcc/jjab107.
Coletta, M., Paroni, M., Alvisi, M. F., De Luca, M., Rulli, E., Mazza, S., Facciotti, F., Lattanzi, G., Strati, F., Abrignani, S., Claudio Fantini, M., Vecchi, M., Geginat, J., & Capriolia, F. (2021). Corrigendum to: Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel Diseases. Journal of Crohn's & colitis, . https://doi.org/10.1093/ecco-jcc/jjab107
Coletta, Marina, et al. "Corrigendum to: Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel Diseases." Journal of Crohn's & colitis vol. (2021). doi: https://doi.org/10.1093/ecco-jcc/jjab107
Coletta M, Paroni M, Alvisi MF, De Luca M, Rulli E, Mazza S, Facciotti F, Lattanzi G, Strati F, Abrignani S, Claudio Fantini M, Vecchi M, Geginat J, Capriolia F. Corrigendum to: Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel Diseases. J Crohns Colitis. 2021 Nov 30; doi: 10.1093/ecco-jcc/jjab107. Epub 2021 Nov 30. PMID: 34850867.
Copy Download .nbib Format: NLM
Ex vivo microRNA and gene expression profiling of human Tr1-like cells suggests a role for miR-92a and -125a in the regulation of EOMES and IL-10R.

European journal of immunology

De Simone M, Chirichella M, Emming S, Mazzara S, Ranzani V, Gruarin P, Moschetti G, Pulvirenti N, Maglie S, Vasco C, Crosti MC, Rossetti G, Pagani M, Abrignani S, Monticelli S, Geginat J.
PMID: 34528258
Eur J Immunol. 2021 Sep 15; doi: 10.1002/eji.202149315. Epub 2021 Sep 15.

Ex vivo gene expression and miRNA profiling of Eomes

Cite
De Simone M, Chirichella M, Emming S, et al. Ex vivo microRNA and gene expression profiling of human Tr1-like cells suggests a role for miR-92a and -125a in the regulation of EOMES and IL-10R. Eur J Immunol. 2021;doi: 10.1002/eji.202149315.
De Simone, M., Chirichella, M., Emming, S., Mazzara, S., Ranzani, V., Gruarin, P., Moschetti, G., Pulvirenti, N., Maglie, S., Vasco, C., Crosti, M. C., Rossetti, G., Pagani, M., Abrignani, S., Monticelli, S., & Geginat, J. (2021). Ex vivo microRNA and gene expression profiling of human Tr1-like cells suggests a role for miR-92a and -125a in the regulation of EOMES and IL-10R. European journal of immunology, . https://doi.org/10.1002/eji.202149315
De Simone, Marco, et al. "Ex vivo microRNA and gene expression profiling of human Tr1-like cells suggests a role for miR-92a and -125a in the regulation of EOMES and IL-10R." European journal of immunology vol. (2021). doi: https://doi.org/10.1002/eji.202149315
De Simone M, Chirichella M, Emming S, Mazzara S, Ranzani V, Gruarin P, Moschetti G, Pulvirenti N, Maglie S, Vasco C, Crosti MC, Rossetti G, Pagani M, Abrignani S, Monticelli S, Geginat J. Ex vivo microRNA and gene expression profiling of human Tr1-like cells suggests a role for miR-92a and -125a in the regulation of EOMES and IL-10R. Eur J Immunol. 2021 Sep 15; doi: 10.1002/eji.202149315. Epub 2021 Sep 15. PMID: 34528258.
Copy Download .nbib Format: NLM
Impact of temporal variability of radon concentration in workplaces on the actual radon exposure during working hours.

Scientific reports

Venoso G, Iacoponi A, Pratesi G, Guazzini M, Boccini L, Corbani E, Bucci S, Leonardi F, Trevisi R, Ampollini M, Antignani S, Caprio M, Carpentieri C, Di Carlo C, Bochicchio F.
PMID: 34417519
Sci Rep. 2021 Aug 20;11(1):16984. doi: 10.1038/s41598-021-96207-9.

For workplaces where significant diurnal variations in radon concentrations are likely, measurements to evaluate average radon concentration during working hours could be useful for planning an optimized protection of workers according to the 2013/59/Euratom Directive. However, very few studies...

Cite
Venoso G, Iacoponi A, Pratesi G, et al. Impact of temporal variability of radon concentration in workplaces on the actual radon exposure during working hours. Sci Rep. 2021;11(1):16984doi: 10.1038/s41598-021-96207-9.
Venoso, G., Iacoponi, A., Pratesi, G., Guazzini, M., Boccini, L., Corbani, E., Bucci, S., Leonardi, F., Trevisi, R., Ampollini, M., Antignani, S., Caprio, M., Carpentieri, C., Di Carlo, C., & Bochicchio, F. (2021). Impact of temporal variability of radon concentration in workplaces on the actual radon exposure during working hours. Scientific reports, 11(1), 16984. https://doi.org/10.1038/s41598-021-96207-9
Venoso, G, et al. "Impact of temporal variability of radon concentration in workplaces on the actual radon exposure during working hours." Scientific reports vol. 11,1 (2021): 16984. doi: https://doi.org/10.1038/s41598-021-96207-9
Venoso G, Iacoponi A, Pratesi G, Guazzini M, Boccini L, Corbani E, Bucci S, Leonardi F, Trevisi R, Ampollini M, Antignani S, Caprio M, Carpentieri C, Di Carlo C, Bochicchio F. Impact of temporal variability of radon concentration in workplaces on the actual radon exposure during working hours. Sci Rep. 2021 Aug 20;11(1):16984. doi: 10.1038/s41598-021-96207-9. PMID: 34417519; PMCID: PMC8379164.
Copy Download .nbib Format: NLM
Ex vivo microRNA and gene expression profiling of human Tr1-like cells suggests a role for miR-92a and -125a in the regulation of EOMES and IL-10R.

European journal of immunology

De Simone M, Chirichella M, Emming S, Mazzara S, Ranzani V, Gruarin P, Moschetti G, Pulvirenti N, Maglie S, Vasco C, Crosti MC, Rossetti G, Pagani M, Abrignani S, Monticelli S, Geginat J.
PMID: 34528258
Eur J Immunol. 2021 Dec;51(12):3243-3246. doi: 10.1002/eji.202149315. Epub 2021 Sep 28.

Ex vivo gene expression and miRNA profiling of Eomes

Cite
De Simone M, Chirichella M, Emming S, et al. Ex vivo microRNA and gene expression profiling of human Tr1-like cells suggests a role for miR-92a and -125a in the regulation of EOMES and IL-10R. Eur J Immunol. 2021;51(12):3243-3246doi: 10.1002/eji.202149315.
De Simone, M., Chirichella, M., Emming, S., Mazzara, S., Ranzani, V., Gruarin, P., Moschetti, G., Pulvirenti, N., Maglie, S., Vasco, C., Crosti, M. C., Rossetti, G., Pagani, M., Abrignani, S., Monticelli, S., & Geginat, J. (2021). Ex vivo microRNA and gene expression profiling of human Tr1-like cells suggests a role for miR-92a and -125a in the regulation of EOMES and IL-10R. European journal of immunology, 51(12), 3243-3246. https://doi.org/10.1002/eji.202149315
De Simone, Marco, et al. "Ex vivo microRNA and gene expression profiling of human Tr1-like cells suggests a role for miR-92a and -125a in the regulation of EOMES and IL-10R." European journal of immunology vol. 51,12 (2021): 3243-3246. doi: https://doi.org/10.1002/eji.202149315
De Simone M, Chirichella M, Emming S, Mazzara S, Ranzani V, Gruarin P, Moschetti G, Pulvirenti N, Maglie S, Vasco C, Crosti MC, Rossetti G, Pagani M, Abrignani S, Monticelli S, Geginat J. Ex vivo microRNA and gene expression profiling of human Tr1-like cells suggests a role for miR-92a and -125a in the regulation of EOMES and IL-10R. Eur J Immunol. 2021 Dec;51(12):3243-3246. doi: 10.1002/eji.202149315. Epub 2021 Sep 28. PMID: 34528258.
Copy Download .nbib Format: NLM
Cost-effectiveness analysis to assess the protection of workers from exposure to radon at work: A first application to Italian retail shops.

Journal of environmental radioactivity

Trevisi R, Antignani S, Botti T, Buresti G, Carpentieri C, Leonardi F, Bochicchio F.
PMID: 34856448
J Environ Radioact. 2021 Nov 29;242:106780. doi: 10.1016/j.jenvrad.2021.106780. Epub 2021 Nov 29.

For the implementation of the requirements in the Council Directive 2013/59/Euratom (2013 EUBSS), the cost-effectiveness analysis (CEA) is generally considered a useful tool to compare different radon policies aimed at reducing radon exposure both at home and at work....

Cite
Trevisi R, Antignani S, Botti T, et al. Cost-effectiveness analysis to assess the protection of workers from exposure to radon at work: A first application to Italian retail shops. J Environ Radioact. 2021;242:106780doi: 10.1016/j.jenvrad.2021.106780.
Trevisi, R., Antignani, S., Botti, T., Buresti, G., Carpentieri, C., Leonardi, F., & Bochicchio, F. (2021). Cost-effectiveness analysis to assess the protection of workers from exposure to radon at work: A first application to Italian retail shops. Journal of environmental radioactivity, 242106780. https://doi.org/10.1016/j.jenvrad.2021.106780
Trevisi, Rosabianca, et al. "Cost-effectiveness analysis to assess the protection of workers from exposure to radon at work: A first application to Italian retail shops." Journal of environmental radioactivity vol. 242 (2021): 106780. doi: https://doi.org/10.1016/j.jenvrad.2021.106780
Trevisi R, Antignani S, Botti T, Buresti G, Carpentieri C, Leonardi F, Bochicchio F. Cost-effectiveness analysis to assess the protection of workers from exposure to radon at work: A first application to Italian retail shops. J Environ Radioact. 2021 Nov 29;242:106780. doi: 10.1016/j.jenvrad.2021.106780. Epub 2021 Nov 29. PMID: 34856448.
Copy Download .nbib Format: NLM
TCTN2: a novel tumor marker with oncogenic properties.

Oncotarget

Cano-Rodriguez D, Campagnoli S, Grandi A, Parri M, Camilli E, Song C, Jin B, Lacombe A, Pierleoni A, Bombaci M, Cordiglieri C, Ruiters MH, Viale G, Terracciano L, Sarmientos P, Abrignani S, Grandi G, Pileri P, Rots MG, Grifantini R.
PMID: 29221125
Oncotarget. 2017 Aug 24;8(56):95256-95269. doi: 10.18632/oncotarget.20438. eCollection 2017 Nov 10.

Tectonic family member 2 (

Cite
Cano-Rodriguez D, Campagnoli S, Grandi A, et al. TCTN2: a novel tumor marker with oncogenic properties. Oncotarget. 2017;8(56):95256-95269doi: 10.18632/oncotarget.20438.
Cano-Rodriguez, D., Campagnoli, S., Grandi, A., Parri, M., Camilli, E., Song, C., Jin, B., Lacombe, A., Pierleoni, A., Bombaci, M., Cordiglieri, C., Ruiters, M. H., Viale, G., Terracciano, L., Sarmientos, P., Abrignani, S., Grandi, G., Pileri, P., Rots, M. G., & Grifantini, R. (2017). TCTN2: a novel tumor marker with oncogenic properties. Oncotarget, 8(56), 95256-95269. https://doi.org/10.18632/oncotarget.20438
Cano-Rodriguez, David, et al. "TCTN2: a novel tumor marker with oncogenic properties." Oncotarget vol. 8,56 (2017): 95256-95269. doi: https://doi.org/10.18632/oncotarget.20438
Cano-Rodriguez D, Campagnoli S, Grandi A, Parri M, Camilli E, Song C, Jin B, Lacombe A, Pierleoni A, Bombaci M, Cordiglieri C, Ruiters MH, Viale G, Terracciano L, Sarmientos P, Abrignani S, Grandi G, Pileri P, Rots MG, Grifantini R. TCTN2: a novel tumor marker with oncogenic properties. Oncotarget. 2017 Aug 24;8(56):95256-95269. doi: 10.18632/oncotarget.20438. eCollection 2017 Nov 10. PMID: 29221125; PMCID: PMC5707019.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 51 entries